Vor Biopharma
Price & Volume
Stats
See more52W Range | $6.50-$49.95 |
Market Cap | $1.1B |
Shares Short | 7M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $180.09 |
News
See moreYahoo Finance • 3 days ago
Sjögren's Syndrome Market to Witness Sustained Growth During the Forecast Period (2026-2036) Due to the Development of Targeted Immunotherapies, FcRn Inhibitors, TYK2 Inhibitors, and Cell Therapies | DelveInsight
Yahoo Finance • 20 days ago
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
Yahoo Finance • 3 months ago
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 4 months ago
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge
About
CEO | Dr. Jean-Paul Kress M.D. |
CFO | Mr. Sandesh Mahatme L.L.M. |
Address | 500 Boylston Street, Boston, MA, United States, 02116 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 76 |